Use of cannabinoids in the treatment of degenerative skeletal muscle diseases
View Patent ↗The present invention relates to the use of cannabinoids in the treatment of degenerative skeletal muscle disease. In particular the degenerative skeletal muscle disease is Duchenne muscular dystrophy (DMD). Preferably the cannabinoids are one or more of: Cannabidiol (CBD); Cannabidivarin (CBDV); and Tetrahydrocannabivarin (THCV).
1. A method of treating a subject suffering from Duchenne muscular dystrophy (DMD) comprising administering cannabidiol (CBD) to the subject in need thereof, wherein the CBD is highly purified.
2. The method of claim 1 , wherein the CBD is administered at a dose between 1 and 1000 mg/kg day.
3. The method of claim 1 , wherein the CBD is comprised in a composition comprising one or more excipients.
4. The method of claim 2 , wherein the CBD is comprised in a composition comprising one or more excipients.